ATOSSA THERAPEUTICS, INC. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2012 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Atossa Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2012 to Q1 2024.
  • Atossa Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $204K.
  • Atossa Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$1.48M.
  • Atossa Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $0.000, a 100% decline from 2021.
  • Atossa Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $113M, a 194% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $204K +$204K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q1 2023 $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q1 2022 $0 -$102M -100% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $102M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q1 2019 $11.3M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q1 2013 $1M +$1.01M Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-15
Q1 2012 -$6.18K* Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.